Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bradley Monk, MD
Department of Obstetrics and Gynecology University of Arizona Cancer Center, USA
Study ChairKOL profile → - Jonathan Ledermann, MD
UCL Cancer Institute, UK
Study Chair - Pfizer CT.gov Call Center
Pfizer
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
319 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mhat for Female Health-Nadezhda Ood
Sofia, Bulgaria
- Shato Ead
Sofia, Bulgaria
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Mcgill University Health Centre-Glen Site
Montreal, Quebec, Canada
- Oncology Pharmacy Mcgill University Health Centre
Montreal, Quebec, Canada
- Chu de Quebec-Universite Laval
Québec, Quebec, Canada
- Klinicki Bolnicki Centar Split
Split, Croatia
- Klinicki Bolnicki Centar Sestre Milosrdnice
Zagreb, Croatia
- East Tallinn Central Hospital
Tallinn, Estonia
- East-Tallinn Central Hospital, Center of Oncology
Tallinn, Estonia
- North Estonia Medical Centre Foundation
Tallinn, Estonia
- North Estonia Medical Centre Foundation, Pharmacy
Tallinn, Estonia
- Tartu University Hospital, Hematology and Oncology Clinic
Tartu, Estonia
- Klinikum Chemnitz Ggmbh
Chemnitz, Germany
- Zentralapotheke Zytostatika
Chemnitz, Germany
- Radiologie Uniklinik Koeln
Cologne, Germany
- Uniklinik Koeln Apotheke
Cologne, Germany
- Uniklinik Koeln Klinik Fuer Frauenheilkunde Und Geburtshilfe
Cologne, Germany
- Johannes Apotheke Klinikversorgung
Gröbenzell, Germany
- Frauenklinik Am Rotkreuzklinikum Muenchen
München, Germany
- Radiologie Muenchen
München, Germany
- Diagnostische Und Interventionelle Radiologie
Potsdam, Germany
- Klinikum Ernst Von Bergmann Ggmbh
Potsdam, Germany
- Universitaetsklinikum Wuerzburg Frauenklinik Und Poliklinik
Würzburg, Germany
- Queen Elizabeth Hospital
Hong Kong, Hong Kong
- the University of Hong Kong
Hong Kong, Hong Kong
- Semmelweis Egyetem Onkologiai Kozpont
Budapest, Hungary
- Debreceni Egyetem Klinikai Gyogyszertar
Debrecen, Hungary
- Debreceni Egyetem Klinikai Kozpont, Szuleszeti Es Nogyogyaszati Klinika
Debrecen, Hungary
- Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Onkologiai Kozpont
Szolnok, Hungary
- Mater Misericordiae University Hospital
Dublin, Dublin, Ireland
- Mater Private Hospital
Dublin, Dublin, Ireland
- Bon Secours Hospital
Cork, Ireland
- Bon Secours Hospital Ireland
Cork, Ireland
- Mater Misericordiae University Hospital
Dublin, Ireland
- Mater Private Hospital
Dublin, Ireland
- Pharmacy Department, St James'S Hospital
Dublin, Ireland
- St James'S Hospital
Dublin, Ireland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 May 2016
- Primary completion
- 7 Sept 2018
- Completion
- 16 May 2019
- Last update posted
- 14 Jul 2020
- Registered enrollment
- 998
- Registry id
- NCT02718417
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.